|View printer-friendly version|
|Audentes Therapeutics Announces Presentation of Data at the American Society of Gene and Cell Therapy Annual Meeting|
Details of the presentations are provided below:
Abstract number: 216
Abstract number: 674
Abstract number: 212
Summary: Bioinformatic comparison of RNA-Seq data from diseased and gene therapy treated muscle reveals gene expression patterns that correlate with therapeutic correction of X-Linked Myotubular Myopathy in dogs.
Abstract number: 103
Summary: A novel bioinformatic method called 'RNA-Seq Tag Counting' processes RNA-Seq data to generate quantitative gene expression values with robust linearity and reproducibility.
About AT132 to Treat X-Linked Mytubular Myopathy
About AT342 to Treat Crigler-Najjar Syndrome
About Audentes Therapeutics, Inc.
For more information regarding Audentes, please visit www.audentestx.com.
Forward Looking Statements
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/audentes-therapeutics-announces-presentation-of-data-at-the-american-society-of-gene-and-cell-therapy-annual-meeting-300450308.html